Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885162095> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2885162095 endingPage "839" @default.
- W2885162095 startingPage "834" @default.
- W2885162095 abstract "The current first-line treatment for management of active thyroid eye disease (TED) is high-dose intravenous corticosteroids, which have the potential for serious adverse effects. Our aim was to evaluate the effect of steroid-sparing agents (SSAs) in patients with moderate-to-severe active TED, using methotrexate as first-line.Presented is a retrospective, four-year, single-centre, consecutive case series of patients with moderate-to-severe TED treated using the Oxford protocol. Treatment modality, disease activity, and adverse effects are reported at presentation, 6- and 12-month follow-up.104 consecutive TED patients treated by the Oxford TED team were reviewed. 24 patients with moderate-to-severe active disease were identified (mean age 46.8 years;12 female) with a mean pretreatment VISA inflammatory index score of 5.5/10 (SD = 1.98; range 1-9). Intravenous methyl-prednisolone (IVMP) and an SSA was commenced in all patients. Mean total steroid dose was 2.72 g (SD = 1.4;1.0-6.9). 38% of patients (n = 9) received ≤1.5 g of IVMP. Only two patients required >4.5 g of IVMP equating to the EUGOGO treatment protocol dose for this patient group. There was significant improvement in inflammatory index score both at the intermediate review (mean score 2.7; SD = 2.8; P < 0.001; mean follow up 25.2 weeks) and at one year or last follow-up (mean score 1.4; SD = 1.5; P < 0.001; mean follow up 48.0 weeks). No serious or long-term adverse effects were reported.This study suggests that the initiation of an SSA, using methotrexate as first-line, with limited adjuvant IVMP is an effective and safe treatment for moderate-to-severely active TED, resulting in a significant reduction in both disease activity and total steroid load." @default.
- W2885162095 created "2018-08-22" @default.
- W2885162095 creator A5047820662 @default.
- W2885162095 creator A5057719508 @default.
- W2885162095 creator A5061988746 @default.
- W2885162095 creator A5082022439 @default.
- W2885162095 creator A5085406064 @default.
- W2885162095 creator A5089628400 @default.
- W2885162095 date "2018-09-11" @default.
- W2885162095 modified "2023-10-03" @default.
- W2885162095 title "Early use of steroid-sparing agents in the inactivation of moderate-to-severe active thyroid eye disease: a step-down approach" @default.
- W2885162095 cites W1973980245 @default.
- W2885162095 cites W2027731772 @default.
- W2885162095 cites W2037440997 @default.
- W2885162095 cites W2048697130 @default.
- W2885162095 cites W2052463348 @default.
- W2885162095 cites W2063426020 @default.
- W2885162095 cites W2110391738 @default.
- W2885162095 cites W2115068422 @default.
- W2885162095 cites W2139030289 @default.
- W2885162095 cites W2149156155 @default.
- W2885162095 cites W2158064334 @default.
- W2885162095 cites W2165941594 @default.
- W2885162095 cites W2167654441 @default.
- W2885162095 cites W2169811058 @default.
- W2885162095 cites W2288910126 @default.
- W2885162095 cites W2311799308 @default.
- W2885162095 cites W2334870842 @default.
- W2885162095 doi "https://doi.org/10.1111/cen.13834" @default.
- W2885162095 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30103255" @default.
- W2885162095 hasPublicationYear "2018" @default.
- W2885162095 type Work @default.
- W2885162095 sameAs 2885162095 @default.
- W2885162095 citedByCount "22" @default.
- W2885162095 countsByYear W28851620952018 @default.
- W2885162095 countsByYear W28851620952019 @default.
- W2885162095 countsByYear W28851620952020 @default.
- W2885162095 countsByYear W28851620952021 @default.
- W2885162095 countsByYear W28851620952022 @default.
- W2885162095 countsByYear W28851620952023 @default.
- W2885162095 crossrefType "journal-article" @default.
- W2885162095 hasAuthorship W2885162095A5047820662 @default.
- W2885162095 hasAuthorship W2885162095A5057719508 @default.
- W2885162095 hasAuthorship W2885162095A5061988746 @default.
- W2885162095 hasAuthorship W2885162095A5082022439 @default.
- W2885162095 hasAuthorship W2885162095A5085406064 @default.
- W2885162095 hasAuthorship W2885162095A5089628400 @default.
- W2885162095 hasConcept C126322002 @default.
- W2885162095 hasConcept C141071460 @default.
- W2885162095 hasConcept C167135981 @default.
- W2885162095 hasConcept C197934379 @default.
- W2885162095 hasConcept C2776652619 @default.
- W2885162095 hasConcept C2776715498 @default.
- W2885162095 hasConcept C2776804153 @default.
- W2885162095 hasConcept C2781059491 @default.
- W2885162095 hasConcept C526584372 @default.
- W2885162095 hasConcept C71924100 @default.
- W2885162095 hasConceptScore W2885162095C126322002 @default.
- W2885162095 hasConceptScore W2885162095C141071460 @default.
- W2885162095 hasConceptScore W2885162095C167135981 @default.
- W2885162095 hasConceptScore W2885162095C197934379 @default.
- W2885162095 hasConceptScore W2885162095C2776652619 @default.
- W2885162095 hasConceptScore W2885162095C2776715498 @default.
- W2885162095 hasConceptScore W2885162095C2776804153 @default.
- W2885162095 hasConceptScore W2885162095C2781059491 @default.
- W2885162095 hasConceptScore W2885162095C526584372 @default.
- W2885162095 hasConceptScore W2885162095C71924100 @default.
- W2885162095 hasIssue "6" @default.
- W2885162095 hasLocation W28851620951 @default.
- W2885162095 hasLocation W28851620952 @default.
- W2885162095 hasOpenAccess W2885162095 @default.
- W2885162095 hasPrimaryLocation W28851620951 @default.
- W2885162095 hasRelatedWork W1979632536 @default.
- W2885162095 hasRelatedWork W2003938723 @default.
- W2885162095 hasRelatedWork W2047967234 @default.
- W2885162095 hasRelatedWork W2118496982 @default.
- W2885162095 hasRelatedWork W2399356565 @default.
- W2885162095 hasRelatedWork W2417930413 @default.
- W2885162095 hasRelatedWork W2439875401 @default.
- W2885162095 hasRelatedWork W2748952813 @default.
- W2885162095 hasRelatedWork W4229366243 @default.
- W2885162095 hasRelatedWork W2525756941 @default.
- W2885162095 hasVolume "89" @default.
- W2885162095 isParatext "false" @default.
- W2885162095 isRetracted "false" @default.
- W2885162095 magId "2885162095" @default.
- W2885162095 workType "article" @default.